New complexities for BRCA1 and BRCA2 - PubMed (original) (raw)

Review

. 2001 Aug 21;11(16):R668-76.

doi: 10.1016/s0960-9822(01)00389-x.

Affiliations

• PMID: 11525763
• DOI: 10.1016/s0960-9822(01)00389-x

Free article

Review

New complexities for BRCA1 and BRCA2

P Kerr et al. Curr Biol. 2001.

Free article

Abstract

A large number of diverse functions have been attributed to the BRCA1 and BRCA2 breast cancer susceptibility genes. Here we review recent progress in the field.

PubMed Disclaimer

Similar articles

• PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
  Zhang F, Ma J, Wu J, Ye L, Cai H, Xia B, Yu X. Zhang F, et al. Curr Biol. 2009 Mar 24;19(6):524-9. doi: 10.1016/j.cub.2009.02.018. Epub 2009 Mar 5. Curr Biol. 2009. PMID: 19268590 Free PMC article.
• New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein.
  Fei P, Yin J, Wang W. Fei P, et al. Cell Cycle. 2005 Jan;4(1):80-6. doi: 10.4161/cc.4.1.1358. Epub 2005 Jan 11. Cell Cycle. 2005. PMID: 15611632 Review.
• Biomedicine. D-Day for BRCA2.
  Witt E, Ashworth A. Witt E, et al. Science. 2002 Jul 26;297(5581):534. doi: 10.1126/science.1074482. Epub 2002 Jun 13. Science. 2002. PMID: 12065747 No abstract available.
• Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.
  Wang W. Wang W. Nat Rev Genet. 2007 Oct;8(10):735-48. doi: 10.1038/nrg2159. Epub 2007 Sep 4. Nat Rev Genet. 2007. PMID: 17768402 Review.
• Hallmarks of 'BRCAness' in sporadic cancers.
  Turner N, Tutt A, Ashworth A. Turner N, et al. Nat Rev Cancer. 2004 Oct;4(10):814-9. doi: 10.1038/nrc1457. Nat Rev Cancer. 2004. PMID: 15510162 Review.

Cited by

• Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays.
  Bassi N, Hovland HN, Rasheed K, Jarhelle E, Pedersen N, Mchaina EK, Bakkan SME, Iversen N, Høberg-Vetti H, Haukanes BI, Knappskog PM, Aukrust I, Ognedal E, Van Ghelue M. Bassi N, et al. BMC Cancer. 2023 Apr 21;23(1):368. doi: 10.1186/s12885-023-10790-w. BMC Cancer. 2023. PMID: 37085799 Free PMC article.
• BRCA1: An Endocrine and Metabolic Regulator.
  Werner H. Werner H. Front Endocrinol (Lausanne). 2022 Mar 31;13:844575. doi: 10.3389/fendo.2022.844575. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35432218 Free PMC article. Review.
• Sequencing of _BRCA1/2_-alterations using NGS-based technology: annotation as a challenge.
  Ebner S, Winkelmann R, Martin S, Köllermann J, Wild PJ, Demes M. Ebner S, et al. Oncotarget. 2022 Mar 3;13:464-475. doi: 10.18632/oncotarget.28213. eCollection 2022. Oncotarget. 2022. PMID: 35251494 Free PMC article.
• Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer.
  Bouberhan S, Philp L, Hill S, Al-Alem LF, Rueda B. Bouberhan S, et al. Cancers (Basel). 2020 May 11;12(5):1206. doi: 10.3390/cancers12051206. Cancers (Basel). 2020. PMID: 32403357 Free PMC article. Review.
• Family history in breast cancer in São Luís, Maranhão, Brazil.
  Ribeiro MH, da Silva MA, Muniz Filho WE, Nascimento AC, Souza RD, Machado CE, Silva DF, de Barros Bezerra GF, de Castro Viana GM, Soares Brandão Nascimento Mdo D. Ribeiro MH, et al. BMC Res Notes. 2016 Mar 10;9:155. doi: 10.1186/s13104-015-1471-7. BMC Res Notes. 2016. PMID: 26966075 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal